Concepedia

Rafel Simó‐Vicens

RS

5

Publications

160

Citations

5

H-Index

2017

Active since

Affiliations

Acesion Pharma (Denmark)(Current)

University of Copenhagen

Rafel Simó‐Vicens is an author at Acesion Pharma (Denmark) specializing in potassium homeostasis, neurophysiology, and electrophysiology.

ORCID

Top concepts

Publications per year

2017–2020

5

Publications

5

Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca <sup>2+</sup> -Activated K <sup>+</sup> Channels in Pigs

Jonas Goldin Diness, Lasse Skibsbye, Rafel Simó‐Vicens et al. · Circulation Arrhythmia and Electrophysiology · 2017 · 72 citations · Full text

A new negative allosteric modulator, AP14145, for the study of small conductance calcium‐activated potassium (K<sub>Ca</sub>2) channels

Rafel Simó‐Vicens, Jeppe Kirchhoff, Bernardo Dolce et al. · British Journal of Pharmacology · 2017 · 37 citations · Full text

Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man

Bo Hjorth Bentzen, Sofia Hammami Bomholtz, Rafel Simó‐Vicens et al. · Frontiers in Pharmacology · 2020 · 28 citations · Full text

The KCa2 Channel Inhibitor AP14145, But Not Dofetilide or Ondansetron, Provides Functional Atrial Selectivity in Guinea Pig Hearts

Jeppe Kirchhoff, Mark Alexander Skarsfeldt, Kalai Mangai Muthukumarasamy et al. · Frontiers in Pharmacology · 2019 · 13 citations · Full text

Effect of antiarrhythmic drugs on small conductance calcium – activated potassium channels

Rafel Simó‐Vicens, Daniel Sauter, Morten Grunnet et al. · European Journal of Pharmacology · 2017 · 10 citations · Full text

, , +12

Rows per page

1–5 of 5